News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mingozzi Federico
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/17/2019 |
4
| Mingozzi Federico (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 12,615 shares
@ $114.5, valued at
$1.4M
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 18,000 options to buy
@ $50.55, valued at
$909.9k
Disposed/sold 50,000 options to buy
@ $59.74, valued at
$3M
Disposed/sold 32,750 restricted stock units
@ $0 |
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Mingozzi Federico (Chief Scientific Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,627 shares
@ $87.98, valued at
$231.1k
Paid exercise price by delivering 733 shares
@ $45.08, valued at
$33k
Exercised 8,375 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/17/2019 |
4
| Mingozzi Federico (Chief Scientific Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $42.73, valued at
$1.5M
Granted 10,000 restricted stock units
@ $0 |
|
| 02/23/2018 |
3
| Mingozzi Federico (Chief Scientific Officer) has filed a Form 3 on Spark Therapeutics, Inc. |
|
|